Company Overview and News

 
Nigeria central bank, MTN getting closer to settlement -minister

1h reuters
LONDON, Oct 17 (Reuters) - Nigeria’s central bank and South African telecommunications firm MTN could soon strike a deal in their dispute over the repatriation of $8.1 billion, Nigeria’s information minister said on Wednesday.
STAN 580001 STAB STAN STAC 2888 SCBFF DBPA DBP

 
Anglo-Gulf Trade Bank aims to bridge trade finance gap with blockchain

1h channelnewsasia
ABU DHABI/LONDON: Anglo-Gulf Trade Bank, a British/UAE start-up, is aiming to shake up trade finance in the region by using blockchain to speed up transactions, becoming the latest financial services firm to adopt the technology.
STAN HCS HSB 0005 580001 STAB STAN STAC 2888 SCBFF HSEA HSEB HSBC HBCYF

 
UPDATE 8-Saudi prince agrees to Khashoggi case investigation as Turks search consulate

23h reuters
RIYADH/ISTANBUL (Reuters) - Saudi Arabia’s crown prince agreed on Tuesday there must be a thorough investigation into the disappearance of journalist Jamal Khashoggi, the United States said, after media reports that Riyadh will acknowledge he was killed in a botched interrogation.
BNPZY STAN 580001 STAB BNPQY STAN STAC 2888 SCBFF LNSTY NYTAB BNPQF

 
Europe's top bankers shun Saudi investment conference

2018-10-16 theedgemarkets
LONDON (Oct 16): The bosses of some of Europe's biggest banks and finance firms have pulled out of a high-profile investment conference in Saudi Arabia, joining a growing list of business chiefs to abandon the event amid widespread concern about the fate of a journalist.
STAN BNPQY SCGLY BNPQF BNPZY SCGLF 580001 STAB STAN STAC 2888 SCBFF LNSTY GLE

 
UPDATE 2-Europe's top bankers shun Saudi investment conference

2018-10-16 reuters
LONDON (Reuters) - The bosses of some of Europe’s biggest banks and finance firms have pulled out of a high-profile investment conference in Saudi Arabia, joining a growing list of business chiefs to abandon the event amid widespread concern about the fate of a journalist.
STAN BNPQY SCGLY BNPQF BNPZY SCGLF 580001 STAB STAN STAC 2888 SCBFF LNSTY GLE

 
More banking executives pull out of Saudi investment conference

2018-10-16 moneycontrol
The chief executives of HSBC, Standard Chartered and Credit Suisse have pulled out of a high profile conference in Saudi Arabia next week, the latest business leaders to abandon the event amid widespread concern about the fate of Saudi journalist Jamal Khashoggi.
STAN 580001 STAB STAN STAC 2888 SCBFF

 
UPDATE 5-Pompeo meets Saudi king on Khashoggi case, Turks study "toxic materials"

2018-10-16 reuters
RIYADH/ISTANBUL (Reuters) - U.S. Secretary of State Mike Pompeo met Saudi Arabia’s King Salman on Tuesday to discuss the disappearance of Saudi journalist Jamal Khashoggi, as Turkish police prepared to search the Saudi consul’s residence in Istanbul in a widening probe.
STAN 580001 STAB STAN STAC 2888 SCBFF NYTAB

 
UPDATE 4-Pompeo meets Saudi king over Khashoggi case, Turks to search consul's residence

2018-10-16 reuters
RIYADH/ISTANBUL (Reuters) - U.S. Secretary of State Mike Pompeo met Saudi Arabia’s King Salman on Tuesday to discuss the disappearance of Saudi journalist Jamal Khashoggi, as Turkish police prepared to search the Saudi consul’s residence in Istanbul in a widening probe.
STAN 580001 STAB STAN STAC 2888 SCBFF NYTAB

 
UPDATE 1-More banking executives pull out of Saudi investment conference

2018-10-16 reuters
LONDON, Oct 16 (Reuters) - The chief executives of HSBC , Standard Chartered and Credit Suisse have pulled out of a high profile conference in Saudi Arabia next week, the latest business leaders to abandon the event amid widespread concern about the fate of a journalist.
STAN 580001 STAB STAN STAC 2888 SCBFF

 
Standard Chartered sees increased China-Africa trade due to U.S. trade war

2018-10-16 reuters
NAIROBI (Reuters) - China is likely to boost imports from African countries as it seeks new sources of commodities in the wake of a trade war with the United States, a senior executive of Standard Chartered Bank [STANB.UL] in China said.
STAN 580001 STAB STAN STAC 2888 SCBFF

 
Standard Chartered sees increased China-Africa trade due to US trade war

2018-10-16 channelnewsasia
China is likely to boost imports from African countries as it seeks new sources of commodities in the wake of a trade war with the United States, a senior executive of Standard Chartered Bank in China said.
STAN 580001 STAB STAN STAC 2888 SCBFF

 
More banking executives pull out of Saudi investment conference

2018-10-16 malaymail
LONDON, Oct 16 — The chief executives of HSBC , Standard Chartered and Credit Suisse have pulled out of a high profile conference in Saudi Arabia next week, the latest business leaders to abandon the event amid widespread concern about the fate of a journalist.
STAN 580001 STAB STAN STAC 2888 SCBFF

 
Banking chiefs at HSBC and Standard Chartered pull out of Saudi conference

2018-10-16 telegraph.co.uk
A number of big-name banking chief executives have bowed to pressure and pulled out of a major investment conference in Saudi Arabia in protest at the Kingdom's alleged involvement in the disappearance of journalist Jamal Khashoggi.
STAN 580001 STAB STAN STAC 2888 SCBFF

19
Deals of the day-Mergers and acquisitions

2018-10-15 reuters
Oct 15 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:
FOX FBU STAN FCREY FRCEF FBU 580001 STAB STAN EPW STAC 2888 SCBFF AAPL GNC HRS IOF FOXA DIS

19
Deals of the day-Mergers and acquisitions

2018-10-15 reuters
Oct 15 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 10.00 GMT on Monday:
FOX FBU STAN FCREY FRCEF FBU 580001 STAB STAN EPW STAC 2888 SCBFF AAPL GNC HRS IOF FOXA DIS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...